well I have had a conservative value of between 3.00-5.00 a share just on the legal deal alone, that valuation does not include any sales
I am not disputing your figures
my understanding is currently bta reliant on gsk to deliver the sales and revenue there is only royalties of 7%
however hopefully bta get a different deal on the new drugs as 7% seems pitiful compared to the expertise in finding the solution
they should get a better deal to share in the profits
cheers
- Forums
- ASX - By Stock
- BTA
- medium-term valuation
medium-term valuation, page-5
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online